SYK · Earnings call · 2026Q3T · Full report

Soft Tissue Augmentation Product

STRYKER CORP · 2026-10-29 · Importance 34 · Surprise 42

Management described ZuriMED’s FiberLocker technology as a differentiated soft-tissue augmentation product with an open system that can attach different materials and an applicator it considers particularly effective. The product is intended to augment rotator-cuff repair, an area management said experiences frequent failures, and is expected to provide clinical benefits. Stryker previously lacked a solution in this area, sees the augmentation market as fast-growing, and plans to provide more information as it launches the product.

Key facts

• Stryker said it had not previously had a soft-tissue augmentation solution and had passed on other products it did not consider sufficiently differentiated.
• ZuriMED's fiber locker technology is designed to increase biomechanical strength in rotator cuff repair and provide a broader orthopedic soft tissue augmentation platform for Stryker.
• Stryker said ZuriMED’s FiberLocker technology is a differentiated soft-tissue augmentation product with an open system that can attach different types of material to provide fixation.
• Stryker said soft-tissue augmentation could provide clinical benefits in rotator cuffs, an area with many failures, and described augmentation as a fast-growing part of the market.
• Stryker said the FiberLocker applicator has a clever design for applying fixation.